Balance Medical: Radiofrequency Ablation System Enters Special Review Procedure for Innovative Medical Devices
Balance Medical announced that its self-developed radiofrequency ablation system has been approved by the National Medical Products Administration's Medical Device Technical Review Center to enter the special review process for innovative medical devices. The system consists of an ablation instrument, ablation forceps, and an ablation pen, specifically designed for cardiac surgery to treat atrial fibrillation, using electrical isolation technology to restore normal heart rhythm
According to the Zhitong Finance APP, Balance Medical (688198.SH) announced that its self-developed radiofrequency ablation system has been approved by the National Medical Products Administration's Medical Device Technical Review Center to enter the special review process for innovative medical devices.
The radiofrequency ablation system consists of three products: the ablation instrument, ablation forceps, and ablation pen, specifically designed for the surgical treatment of persistent and permanent atrial fibrillation. This product is based on the principles of traditional maze surgery, using direct visualization surgery to electrically isolate atrial tissue, creating transmurally continuous and irreversible linear lesions, thereby eliminating atrial fibrillation triggers and maintaining the substrate to restore sinus rhythm
